Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2017
SMARCE1 is required for the invasive progression of in situ cancersEthan S Sokol, Yu-Xiong Feng, Dexter X Jin, et al.
Cancer Discovery|April 8, 2014
Epithelial-to-mesenchymal transition activates PERK-eIF2α and sensitizes cells to endoplasmic reticulum stressYu-Xiong Feng, Ethan S Sokol, Catherine A Del Vecchio, et al.
JCO Precision Oncology|November 22, 2023
Homologous Recombination Deficiency Landscape of Breast Cancers and Real-World Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Patients With Somatic BRCA1/2, Germline PALB2, or Homologous Recombination Deficiency SignatureFelipe Batalini, Russell W Madison, Ethan S Sokol, et al.
Molecular Cancer Therapeutics|July 8, 2025
KRAS codon-specific mutations differentially toggle PI3K pathway signaling and alter sensitivity to inavolisib (GDC-0077)Kyung W Song, Christy C Ong, Eva Lin, et al.
Cancer Research|June 8, 2026
Deficiency in POLE Exonuclease Causes Synthetic Lethality in Highly Aneuploid Cancer CellsEun Jung Kim, Dexter X Jin, Alejandro M Chibly, et al.
The Oncologist|May 22, 2022
Association of CD274 (PD-L1) Copy Number Changes with Immune Checkpoint Inhibitor Clinical Benefit in Non-Squamous Non-Small Cell Lung CancerKarthikeyan Murugesan, Dexter X Jin, Leah A Comment, et al.
JTO Clinical and Research Reports|August 1, 2025
Real-World Validity of Tissue-Agnostic Circulating Tumor DNA Response Monitoring in Lung Cancers Treated With Chemotherapy, Immunotherapy, or Targeted AgentsAnne C Chiang, Russell W Madison, Zoe June Assaf, et al.
Nature Communications|December 5, 2022
Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancerSmruthy Sivakumar, Dexter X Jin, Hanna Tukachinsky, et al.
Cancer Research Communications|August 8, 2024
Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic FeaturesN Ari Wijetunga, Kathryn H Gessner, Krishna Kanchi, et al.
JCO Precision Oncology|September 28, 2023
Pan-Cancer Analysis of Copy-Number Features Identifies Recurrent Signatures and a Homologous Recombination Deficiency Biomarker to Predict Poly (ADP-Ribose) Polymerase Inhibitor ResponseJay A Moore, Kuei-Ting Chen, Russell Madison, et al.
Pageof 4